Abstract: A tripod system includes a tripod having a center column, a plurality of legs coupled to the center column, a battery receptacle supported by the center column, and a head supported by the center column. The battery receptacle is configured to receive a battery pack such that the battery pack provides power to the tripod. The tripod system also includes a luminaire removably coupled to the head such that the luminaire is configured to be electrically powered by the battery pack through the tripod. The luminaire is removable from the head and configured to be coupled directly to the battery pack such that the battery pack is secured to the luminaire and provides power to the luminaire. The head is pivotally coupled to an end of the center column.

Abstract: Systems and methods of expanding a bagging system are provided. In one exemplary embodiment, a method is performed by a bagging station device configured to couple to a terminal station device. The bagging station device includes an outer expandable frame, an inner expandable frame having an inner movable mechanism coupled between first and second inner frame portions, first and second panels disposed on the corresponding first and second inner frame portions, and a set of load sensors coupled between the inner and outer expandable frames. The method includes sending, by each load sensor, to the terminal station device, a measurement of a load associated with one or more objects placed on a surface of the first or second panel. The inner movable mechanism is configured to enable the first or second panel to move along a longitudinal plane of the inner expandable frame.

Abstract: Described herein are benzoxazepin oxazolidinone compounds with phosphoinositide-3 kinase (PI3K) modulation activity or function having the Formula I structure: or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula I compounds, as well as methods of using such PI3K modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon PI3K dysregulation.

Abstract: A method for producing a bicyclic hydrocarbon molecule includes oxidizing a terpene molecule to provide a first intermediate compound, wherein the first intermediate compound includes an aldehyde functional group, reacting the first intermediate compound with a 1,3-diene molecule to form a second intermediate compound including the aldehyde functional group, and reducing the second intermediate compound to yield a first bicyclic hydrocarbon molecule, wherein reducing the second intermediate compound includes removing the aldehyde functional group.

Abstract: A method includes receiving an input text utterance to be synthesized into expressive speech having an intended prosody and a target voice and generating, using a first text-to-speech (TTS) model, an intermediate synthesized speech representation for the input text utterance. The intermediate synthesized speech representation possesses the intended prosody. The method also includes providing the intermediate synthesized speech representation to a second TTS model that includes an encoder portion and a decoder portion. The encoder portion is configured to encode the intermediate synthesized speech representation into an utterance embedding that specifies the intended prosody. The decoder portion is configured to process the input text utterance and the utterance embedding to generate an output audio signal of expressive speech that has the intended prosody specified by the utterance embedding and speaker characteristics of the target voice.

Abstract: This invention relates to a patient interface, such as a nasal cannula, comprising a body to be positioned upon a user (preferably such as a user's face), the body including at least one (and preferably a pair of) nasal prong(s), the or each nasal prong including a lumen capable of being fluidly connected thereto for fluid communication with a supply of breathable gas, the or each nasal prong to be in a configuration either inserted into, or to direct a flow of gas toward, a nare or the nares of the user's nose, wherein the body includes at least one element responsive to force(s) or movement(s), or both, experienced by at least a first region of the patient interface.

Abstract: A wear pad assembly is provided for a root of a fan blade. The wear pad assembly includes a first tapered side piece including an edge and first and second ends, a second tapered side piece including an edge and first and second ends, a bottom piece extending between the respective edges of the first and second tapered side pieces and including first and second ends and first and second end pieces by which the respective first and second ends of the first and second tapered side pieces are connectable with the first and second ends of the bottom piece, respectively, to form a wear pad having a similar shape as the root.

Abstract: A network device is configured to (i) play back a media item indicated by a remote playback queue provided by a cloud-based computing system, (ii) receive an indication that a playback device is available for playback, (iii) display a now playing screen including (a) information identifying the media item, and (b) an icon that indicates that the network device is not in a connected state with any other network device, (iv) receive a first input selecting the icon, (v) in response to the first input, display a list of one or more available network devices including the playback device, (vi) receive a second input selecting the playback device from the list (vii) after receiving the second input, update the list to indicate that the playback device is selected for playback of the remote playback queue, and (viii) transfer playback of the remote playback queue from the network device to the playback device.

Abstract: A tripod for use with an accessory device and a battery pack includes a main body, a battery receptacle, and a head. The main body includes a center column having a first end, a second end opposite the first end, and a longitudinal axis extending through the first end and the second end. The main body also includes a plurality of legs coupled to the center column. The battery receptacle is supported on the main body. The battery receptacle has a first interface configured to mechanically and electrically couple to the battery pack. The head is supported at the second end of the center column. The head has a second interface configured to mechanically and electrically couple to the accessory device. The first interface has a complementary configuration to the second interface.

Abstract: A patient interface can have a first body that rests on a first portion of a face of a patient, a second body that rests on a second portion of the face of the patient, and a bridge linking the first and second bodies. The patient interface can have an attachment structure that couples with a complementary fixation structure positioned on the face of the patient to secure the patient interface to the face. The fixation structure can include an adhesive to adhere the fixation structure, and thus the attached patient interface, to the face. The fixation structure can have an edge that is shaped to reduce the tendency for the fixation structure to be lifted off the face when the patient interface is detached from the face.

Abstract: An expiratory limb is provided that is configured to remove humidified gases from a patient and configured to provide improved drying performance by providing a tailored temperature profile along the limb. Limbs for providing humidified gases to and/or removing humidified gases from a patient are also provided, the limbs having improved gas residence time at constant volumetric flow rate. The improved residence time can be achieved by providing a limb comprising multiple lumens.

Abstract: The present invention relates to compounds having activity at both the human glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The present invention also relates to compounds having an extended duration of action at each of these receptors. Furthermore, the present invention relates to compounds that may be administered orally. Compounds may be useful in the treatment of type 2 diabetes mellitus (“T2DM”). Also, the compounds may be useful in the treatment of obesity.

Abstract: Methods for generating an object based audio program which is renderable in a personalizable manner, e.g., to provide an immersive, perception of audio content of the program. Other embodiments include steps of delivering (e.g., broadcasting), decoding, and/or rendering such a program. Rendering of audio objects indicated by the program may provide an immersive experience. The audio content of the program may be indicative of multiple object channels (e.g., object channels indicative of user-selectable and user-configurable objects, and typically also a default set of objects which will be rendered in the absence of a selection by a user) and a bed of speaker channels. Another aspect is an audio processing unit (e.g., encoder or decoder) configured to perform, or which includes a buffer memory which stores at least one frame (or other segment) of an object based audio program (or bitstream thereof) generated in accordance with, any embodiment of the method.

Abstract: A vacuum cleaner including a debris collector having a base, a longitudinal axis extending perpendicular to the base, and a plurality of housing segments coupled to the base. A lid is coupled to the debris collector and a suction source is configured to generate an airflow to draw fluid and debris into the debris collector. The vacuum cleaner further includes an exhaust passageway downstream from the suction source for discharging the airflow from the debris collector. The debris collector is moveable between a collapsed position and an extended position along a longitudinal axis, thereby changing a distance between the base and the lid. At least one of the plurality of housing segments nest within a remainder of the plurality of housing segments when the debris collector is in the collapsed position.

Abstract: A hydrogel contact lens formulation for forming the polymeric body of a hydrogel contact lens comprising: a first high energy visible light (HEVL) absorber comprising a benzotriazole moiety and a second different high energy visible light (HEVL) absorber comprising a benzotriazole moiety, and a hydrogel contact lens obtained from the polymerisation of the formulation.

Abstract: A closure system including a cap and a spout, where the cap and/or spout contain at least one discrete layer of barrier material. In one example, the spout includes a conduit and a seal member, the conduit being arranged about an imaginary axis and the seal member having one or more surfaces configured to be secured to a container. The cap includes an inner circumferential surface, the inner circumferential surface arranged to encompass the conduit. The cap also includes a first discrete layer of thermoplastic resin and a first discrete layer of barrier material and the seal member includes a second discrete layer of thermoplastic resin and a second discrete layer of barrier material.

Abstract: A method includes obtaining training data including a plurality of training audio signals and corresponding transcripts. Each training audio signal is spoken by a target speaker in a first accent/dialect. For each training audio signal of the training data, the method includes generating a training synthesized speech representation spoken by the target speaker in a second accent/dialect different than the first accent/dialect and training a text-to-speech (TTS) system based on the corresponding transcript and the training synthesized speech representation. The method also includes receiving an input text utterance to be synthesized into speech in the second accent/dialect. The method also includes obtaining conditioning inputs that include a speaker embedding and an accent/dialect identifier that identifies the second accent/dialect.

Abstract: In one embodiment, an apparatus for docking vehicles includes a housing structure comprising two side portions and a top portion connecting the two side portions, the two side portions and the top portion forming a cavity for receiving a portion of a vehicle, an electrically-powered locking assembly, carried by the housing structure, for securing the housing structure to the vehicle in response to the portion of the vehicle being received by the cavity of the housing structure, an electrically-powered communication device, coupled to the housing structure, for enabling data communication over a network, and a solar panel, carried by an external surface of one of the side portions of the housing structure, for independently converting light received by the solar panel into electrical energy.

Abstract: The present invention relates to compounds having activity at both the human glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The present invention also relates to compounds having an extended duration of action at each of these receptors. Furthermore, the present invention relates to compounds that may be administered orally. Compounds may be useful in the treatment of type 2 diabetes mellitus (“T2DM”). Also, the compounds may be useful in the treatment of obesity.